ARCHIVES

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

This article is from The Cancer Letter archive.

Vol. 01 No. 25 | June 20, 1975

Download PDF Visit The Full Archive

Related Articles

Professional Societies: Three Groups To File brief In Fisher’s Appeal

October 11, 1996

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

Central Line Safety Intervention Lowers Patient Infection Rate

October 25, 2013

Working Group Nears Agreement On New Core Grant Guidelines

January 16, 1981

DCPC Advisor O Trial Of Cervical Lesion Management With HPV

June 3, 1994